Home-based activity and sleep monitoring of clinical trial patients can provide important insights into treatment effects across a broad range of disease indications. Actigraphy devices offer an opportunity to capture these data remotely. However, careful consideration must be taken to streamline the experience for patients and site staff who are using and
implementing remote sensors. Additionally, it is important that sensor data are actionable and suitable for analysis and endpoint derivation.
Signant Health’s Sensors & Wearables solution allows you to capture objective clinical outcomes data in real-world settings and review it with ease. It is delivered via TrialMax®, our industry leading electronic clinical outcome assessment (eCOA) platform that includes out-of-the-box, regulatory compliant integrations to a range of devices, such as glucose and respiratory monitors. Its integration with ActiGraph, a leading provider of research-grade wearable activity and sleep monitoring solutions, which are the most widely used and extensively validated devices of their kind, provides a simple way to incorporate activity and sleep monitoring alongside eCOAs in your clinical trials.
Read more in the above brochure.